Filing Details
- Accession Number:
- 0001209191-20-034415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-04 16:00:13
- Reporting Period:
- 2020-06-02
- Accepted Time:
- 2020-06-04 16:00:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651311 | Merus N.v. | MRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790357 | Mark Throsby | C/O Merus N.v. Yalelaan 62 Utrecht P7 3584 CM | Evp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2020-06-02 | 368 | $14.19 | 45,175 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Amount represents the weighted average price of shares sold, which ranged from $13.85 to $14.56. Details of individual transactions are available upon request.
Billionaire Hedge Funds
